Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients

Gerd Fätkenheuer, T.M. Jenkins, Andreas Plettenburg et al.|AIDS|2009

Cited by 43